Statin Therapy for Primary and Secondary Prevention in Older Adults

被引：1

作者：

Bao, Alicia ^{[1
]}

Karalis, Dean G. ^{[1
]}

机构：

[1] Jefferson Univ Hosp, Sidney Kimmel Med Coll, Dept Cardiol, 227 North Broad St,Suite 200, Philadelphia, PA 19107 USA

来源：

CURRENT ATHEROSCLEROSIS REPORTS | 2024年 / 27卷 / 01期

关键词：

ASCVD prevention; Older adults; Statins; LDL cholesterol reduction; CARDIOVASCULAR EVENTS; DRUG INTERACTIONS; LDL CHOLESTEROL; SENSITIVE ASSAY; HEART-FAILURE; RISK; DISEASE; MORTALITY; INDIVIDUALS; PRAVASTATIN;

D O I：

10.1007/s11883-024-01257-9

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

Purpose of ReviewAlthough statin therapy is well established to prevent atherosclerotic vascular disease (ASCVD) events in adults 40 to 75 years of age, it is less clear whether older adults benefit from statin therapy. The purpose of this review is to summarize the current evidence and guidelines on statin use for primary and secondary prevention in older patients.Recent FindingsModerate to high intensity statin therapy decreases cardiovascular event rates in older patients with or at risk for ASCVD. Cardiac biomarkers and coronary calcium scoring can identify older patients at higher ASCVD risk who may benefit from statin therapy.SummaryAge alone should not be a deterrent to statin therapy in older patients. The decision to initiate statin therapy should occur after a patient to clinician discussion based on the patient's overall ASCVD risk and weighed against other clinical factors that influence the patient's life expectancy and quality of life.

引用

页数：8

共 35 条

[1] Statins for secondary prevention in elderly patients - A hierarchical Bayesian meta-analysis [J].

Afilalo, Jonathan ;

Duque, Gustavo ;

Steele, Russell ;

Jukema, J. Wouter ;

de Craen, Anton J. M. ;

Eisenberg, Mark J. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (01) :37-45

[2]

[Anonymous], 2020, Older population and aging

[3] Association of statin use in older people primary prevention group with risk of cardiovascular events and mortality: a systematic review and meta-analysis of observational studies [J].

Awad, Kamal ;

Mohammed, Maged ;

Zaki, Mahmoud Mohamed ;

Abushouk, Abdelrahman I. ;

Lip, Gregory Y. H. ;

Blaha, Michael J. ;

Lavie, Carl J. ;

Toth, Peter P. ;

Jukema, J. Wouter ;

Sattar, Naveed ;

Banach, Maciej .

BMC MEDICINE, 2021, 19 (01)

[4] Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials [J].

Baigent, C. ;

Blackwell, L. ;

Emberson, J. ;

Holland, L. E. ;

Reith, C. ;

Bhala, N. ;

Peto, R. ;

Barnes, E. H. ;

Keech, A. ;

Simes, J. ;

Collins, R. .

LANCET, 2010, 376 (9753) :1670-1681

[5] Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA) [J].

Budoff, Matthew J. ;

Young, Rebekah ;

Burke, Gregory ;

Carr, J. Jeffrey ;

Detrano, Robert C. ;

Folsom, Aaron R. ;

Kronmal, Richard ;

Lima, Joao A. C. ;

Liu, Kiang J. ;

McClelland, Robyn L. ;

Michos, Erin ;

Post, Wendy S. ;

Shea, Steven ;

Watson, Karol E. ;

Wong, Nathan D. .

EUROPEAN HEART JOURNAL, 2018, 39 (25) :2401-+

[6] Cardiovascular events with absent or minimal coronary calcification: The Multi-Ethnic Study of Atherosclerosis (MESA) [J].

Budoff, Matthew J. ;

McClelland, Robyn L. ;

Nasir, Khurram ;

Greenland, Philip ;

Kronmal, Richard A. ;

Kondos, George T. ;

Shea, Steven ;

Lima, Joao A. C. ;

Blumenthal, Roger S. .

AMERICAN HEART JOURNAL, 2009, 158 (04) :554-561

[7] Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20 536 high-risk individuals: a randomised controlled trial [J].

Bulbulia, R. ;

Bowman, L. ;

Wallendszus, K. ;

Parish, S. ;

Armitage, J. ;

Peto, R. ;

Collins, R. ;

Meade, T. ;

Sleight, P. ;

Armitage, J. ;

Parish, S. ;

Youngman, L. ;

Buxton, M. ;

de Bono, D. ;

George, C. ;

Fuller, J. ;

Keech, A. ;

Mansfi, A. ;

Pentecost, B. ;

Simpson, D. ;

Warlow, C. ;

McNamara, J. ;

O'Toole, L. ;

Doll, R. ;

Wilhelmsen, L. ;

Fox, K. M. ;

Hill, C. ;

Sandercock, P. .

LANCET, 2011, 378 (9808) :2013-2020

[8] C-Reactive Protein and Risk of Cardiovascular Events and Mortality in Patients with Various Cardiovascular Disease Locations [J].

Burger, Pascal M. ;

Pradhan, Aruna D. ;

Dorresteijn, Jannick A. N. ;

Koudstaal, Stefan ;

Teraa, Martin ;

de Borst, Gert J. ;

van der Meer, Manon G. ;

Mosterd, Arend ;

Ridker, Paul M. ;

Visseren, Frank L. J. .

AMERICAN JOURNAL OF CARDIOLOGY, 2023, 197 :13-23

[9] Association of Serial Measures of Cardiac Troponin T Using a Sensitive Assay With Incident Heart Failure and Cardiovascular Mortality in Older Adults [J].

deFilippi, Christopher R. ;

de Lemos, James A. ;

Christenson, Robert H. ;

Gottdiener, John S. ;

Kop, Willem J. ;

Zhan, Min ;

Seliger, Stephen L. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (22) :2494-2502

[10] Age-related differences in the prevalence of potential drug-drug interactions in ambulatory dyslipidaemic patients treated with statins [J].

Egger, Sabin S. ;

Bravo, Alexandra E. Raetz ;

Hess, Lorenzo ;

Schlienger, Raymond G. ;

Kraehenbuehl, Stephan .

DRUGS & AGING, 2007, 24 (05) :429-440

← 1 2 3 4 →